These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4891871)

  • 1. [Characteristics of the neuromuscular defect in myasthenia (review)].
    Gekhm BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(1):139-44. PubMed ID: 4891871
    [No Abstract]   [Full Text] [Related]  

  • 2. The kinetics of transmitter release in myasthenia gravis. I. An electrophysiological analysis of the storage of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1972; 12(5):443-88. PubMed ID: 4350884
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental autoimmune myasthenia gravis: effects of calcium and potassium on the spontaneous release of neuromuscular transmitter.
    Kim YI; Sanders DB
    Exp Neurol; 1978 Sep; 61(2):311-7. PubMed ID: 710555
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates.
    Cull-Candy SG; Miledi R; Uchitel OD
    Nature; 1980 Jul; 286(5772):500-2. PubMed ID: 7402330
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myasthenia gravis].
    Abe Y; Nakai K; Oki K; Nukada T; Miyai K
    Nihon Rinsho; 1967 Dec; 25(12):2809-15. PubMed ID: 5627763
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphorrhage localized to the muscle end-plate in myasthenia gravis.
    Pascuzzi RM; Campa JF
    Arch Pathol Lab Med; 1988 Sep; 112(9):934-7. PubMed ID: 3415445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine utulization in myasthenia gravis.
    Thesleff S
    Ann N Y Acad Sci; 1966 Jan; 135(1):195-208. PubMed ID: 5221341
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction. Biochemical basis for disease of the neuromuscular junction.
    Agius MA
    Ann N Y Acad Sci; 2003 Sep; 998():1. PubMed ID: 14592856
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylcholine receptor and myasthenia gravis.
    Fulpius BW; Zurn AD; Granato DA; Leder RM
    Ann N Y Acad Sci; 1976; 274():116-29. PubMed ID: 786106
    [No Abstract]   [Full Text] [Related]  

  • 10. Coexisting childhood schizophrenia and myasthenia gravis treated successfully with neostigmine bromide.
    Schnackenberg RC; Holmes G
    Am J Psychiatry; 1977 Sep; 134(9):1025-7. PubMed ID: 900286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eaton-Lambert syndrome: acetylcholine and choline acetyltransferase in skeletal muscle.
    Molenaar PC; Newsom-Davis J; Polak RL; Vincent A
    Neurology; 1982 Sep; 32(9):1061-5. PubMed ID: 6287358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol in myasthenia gravis.
    Paz ML; Barrantes FJ
    Arch Biochem Biophys; 2021 Apr; 701():108788. PubMed ID: 33548213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism.
    Oda K; Lennon VA; Lambert EH; Palmer AC
    Muscle Nerve; 1984; 7(9):717-24. PubMed ID: 6543920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The neuromuscular junction in myasthenia. Human and experimental morphological data (author's transl)].
    Fardeau M
    Ann Chir; 1980 Mar; 34(3):140-6. PubMed ID: 6989315
    [No Abstract]   [Full Text] [Related]  

  • 18. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
    Nigrovic V; Amann A; Bhatt S
    Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis and autoimmunity.
    Whitaker JN
    Adv Intern Med; 1980; 26():489-510. PubMed ID: 6164271
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.